Health authorities in Dallas first reported the death Dec. 31. The boy had underlying health conditions and represented Dallas County’s first death linked to e-cigarette or vaping product use-associated lung injury, or EVALI.
As of Jan. 7, the CDC has confirmed 2,602 EVALI hospitalizations nationwide, including 57 deaths.
The rate of new EVALI cases has declined since peaking in September. However, the CDC is still warning Americans to avoid using vaping products that contain THC. The agency has identified a thickening agent called vitamin E acetate as the likely culprit of the illnesses but said other chemicals cannot be ruled out yet.
More articles on clinical leadership and infection control:
Popular care program doesn’t significantly cut readmission rates, study finds
Another family joins mold-related class-action suit against Seattle Children’s
Palliative care linked to a 10% drop in ICU use for terminal patients
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
